Crystal-induced joint inflammation caused by a deposit type other than urate or calcium pyrophosphate dihydrate, with the affected joint not documented or not specified in the record.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 8
- Region
- General
Documentation tips
What should appear in the chart to support M11.80.
Source · Editorial brief grounded in 5 cited references ↓
- Record the specific joint by name — knee, wrist, shoulder, etc. — so the site-specific M11.8x subcodes can be used instead of this unspecified-site fallback.
- Document crystal type explicitly: CPPD, hydroxyapatite, or other — so the correct parent code within M11 is applied rather than defaulting to M11.8x.
- Include synovial fluid analysis results (CPP crystal identification) or imaging findings (chondrocalcinosis on X-ray) to clinically validate the crystal arthropathy diagnosis.
- If multiple joints are involved, document each joint separately; ICD-10-CM does not have a polyarticular code for M11.8, so each affected site requires its own code.
- Note whether the condition is acute (flare) or chronic, as this affects medical necessity documentation for joint aspiration and corticosteroid injection claims.
Related CPT procedures
Procedure codes commonly billed with M11.80. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M11.80 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M11.80 when the joint is documented elsewhere in the note — always check imaging reports, physical exam findings, and prior visit records before accepting 'unspecified site.'
- Confusing M11.80 (other specified crystal arthropathy, unspecified site) with M11.90 (crystal arthropathy, unspecified type and site) — M11.80 implies the crystal type is specified (e.g., CPPD) but the site is not; M11.90 is unspecified on both dimensions.
- Coding chondrocalcinosis to M11.80 when the joint is documented — chondrocalcinosis with a known joint maps to M11.2x site-specific subcodes, not M11.8x.
- Failing to code gout separately: gout (M10.-) is excluded from M11 and requires its own code if that is the documented diagnosis.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M11.80 covers crystal arthropathies that fall outside the named subtypes in category M11 — specifically not hydroxyapatite deposition disease (M11.0), familial chondrocalcinosis (M11.1), or idiopathic chondrocalcinosis (M11.2) — and where no anatomic site is documented. The approximate synonym listed in the ICD-10-CM index is calcium pyrophosphate deposition disease (CPPD), making this a common landing code when a provider documents CPPD or pseudogout without specifying the joint involved.
This is a site-unspecified code and should be a last resort. If imaging, synovial fluid analysis, or the clinical note identifies the joint, use the site-specific M11.8x codes instead (e.g., M11.861 for right knee, M11.862 for left knee). The unspecified-site code is appropriate only when the joint genuinely cannot be identified from the documentation — not as a shortcut when site information exists elsewhere in the chart.
M11.80 maps to MS-DRG 553 (Bone diseases and arthropathies with MCC) and 554 (without MCC). Because DRG assignment can shift based on comorbidities, ensure all concurrent conditions are coded to maximize appropriate reimbursement and avoid a DRG mismatch on audit.
Sibling codes
Other billable codes under M11.8 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When is M11.80 the correct code versus a site-specific M11.8x code?
02Can M11.80 be used for pseudogout?
03How does M11.80 differ from M11.90?
04Is M11.80 appropriate for chondrocalcinosis?
05What CPT codes are commonly billed alongside M11.80?
06Does M11.80 require a 7th character extension?
07Which MS-DRGs does M11.80 map to?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M11-/M11.80
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M11.80
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M11.8
- 05pmc.ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC6918617/
Mira AI Scribe
The Mira AI Scribe captures crystal type (CPPD, hydroxyapatite, or other), the specific joint(s) involved, synovial fluid crystal findings, and any imaging evidence of chondrocalcinosis or soft-tissue calcification. Locking in the affected site at the point of care prevents a drop to M11.80 and lets the coder assign the more specific M11.8x site code — avoiding an unspecified-site flag on payer audit and supporting medical necessity for joint aspiration or corticosteroid injection claims.
See how Mira captures M11.80 documentation